162 related articles for article (PubMed ID: 10030240)
1. Decrease of serum levels of soluble CD23 during immunotherapy in patients with perennial allergic rhinitis.
Tanaka A; Ohashi Y; Nakai Y
Ann Otol Rhinol Laryngol; 1999 Feb; 108(2):193-200. PubMed ID: 10030240
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy decreases seasonal rise in serum-soluble CD23 in seasonal allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
Laryngoscope; 1998 May; 108(5):706-11. PubMed ID: 9591550
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD23 in allergic diseases.
Rogala B; Rymarczyk B
Arch Immunol Ther Exp (Warsz); 1999; 47(4):251-5. PubMed ID: 10483874
[TBL] [Abstract][Full Text] [Related]
4. Soluble intercellular adhesion molecule-1 level in sera is elevated in perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
Laryngoscope; 1997 Jul; 107(7):932-5. PubMed ID: 9217134
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy.
Ohashi Y; Nakai Y; Sakamoto H; Ohno Y; Sugiura Y; Okamoto H; Tanaka A; Kakinoki Y; Kishimoto K; Hayashi M
Ann Allergy Asthma Immunol; 1996 Sep; 77(3):203-8. PubMed ID: 8814045
[TBL] [Abstract][Full Text] [Related]
6. Ten-year follow-up study of allergen-specific immunoglobulin E and immunoglobulin G4, soluble interleukin-2 receptor, interleukin-4, soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in serum of patients on immunotherapy for perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Kato A; Masamoto T; Sakamoto H; Yamada K
Scand J Immunol; 1998 Feb; 47(2):167-78. PubMed ID: 9496694
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble CD23 in patients with asthma or rhinitis monosensitive to Parietaria. Its relation to total serum IgE levels and eosinophil cationic protein during and out of the pollen season.
Di Lorenzo G; Drago A; Pellitteri ME; Candore G; Colombo A; Potestio M; Di Salvo A; Mansueto S; Caruso C
Allergy Asthma Proc; 1999; 20(2):119-25. PubMed ID: 10209690
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy suppresses both Th1 and Th2 responses by allergen stimulation, but suppression of the Th2 response is a more important mechanism related to the clinical efficacy of immunotherapy for perennial allergic rhinitis.
Tanaka A; Ohashi Y; Kakinoki Y; Nakai Y
Scand J Immunol; 1998 Aug; 48(2):201-11. PubMed ID: 9716113
[TBL] [Abstract][Full Text] [Related]
9. Serologic study of the working mechanisms of immunotherapy for children with perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Kato A; Masamoto T; Yamada K; Hayashi M
Arch Otolaryngol Head Neck Surg; 1998 Dec; 124(12):1337-46. PubMed ID: 9865756
[TBL] [Abstract][Full Text] [Related]
10. Clinical role of soluble adhesion molecules during immunotherapy for perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Yamada K; Hayashi M
Arch Otolaryngol Head Neck Surg; 1998 Jan; 124(1):41-5. PubMed ID: 9440779
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of soluble components of receptors with weak affinity for IgE (sCD23) in children with pollinosis given specific immunotherapy].
Boznański A; Willak-Janc E; Domanasiewicz M; Pirogowicz I; Widerska A
Pneumonol Alergol Pol; 1996; 64(7-8):386-91. PubMed ID: 8983438
[TBL] [Abstract][Full Text] [Related]
12. Expression of membrane-bound CD23 in nasal mucosal B cells from patients with perennial allergic rhinitis.
Horiguchi S; Okamoto Y; Chazono H; Sakurai D; Kobayashi K
Ann Allergy Asthma Immunol; 2005 Feb; 94(2):286-91. PubMed ID: 15765747
[TBL] [Abstract][Full Text] [Related]
13. Platelet aggregation in IgE-mediated allergy with elevated soluble Fc epsilon RII/CD23 level.
Rogala B; Gumprecht J; Gawlik R; Strojek K
J Investig Allergol Clin Immunol; 1995; 5(3):161-5. PubMed ID: 7582163
[TBL] [Abstract][Full Text] [Related]
14. Natural course of serum-specific immunoglobulin E and immunoglobulin G4 for a span of eight years in untreated patients with perennial allergic rhinitis.
Ohashi Y; Nakai Y; Ohno Y; Okamoto H; Kakinoki Y; Masamoto T; Tanaka A; Hayashi M
Laryngoscope; 1997 Mar; 107(3):382-5. PubMed ID: 9121318
[TBL] [Abstract][Full Text] [Related]
15. Effect of immunotherapy on serum levels of eosinophil cationic protein in perennial allergic rhinitis.
Ohashi Y; Nakai Y; Kakinoki Y; Ohno Y; Sakamoto H; Kato A; Tanaka A
Ann Otol Rhinol Laryngol; 1997 Oct; 106(10 Pt 1):848-53. PubMed ID: 9342981
[TBL] [Abstract][Full Text] [Related]
16. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
[TBL] [Abstract][Full Text] [Related]
18. Serum level of interleukin-4 in patients with perennial allergic rhinitis during allergen-specific immunotherapy.
Ohashi Y; Nakai Y; Okamoto H; Ohno Y; Sakamoto H; Sugiura Y; Kakinoki Y; Tanaka A; Kishimoto K; Washio Y; Hayashi M
Scand J Immunol; 1996 Jun; 43(6):680-6. PubMed ID: 8658058
[TBL] [Abstract][Full Text] [Related]
19. Effect of allergen immunotherapy on soluble adhesion molecules.
Pereira-Santos MC; Pregal AL; Spínola-Santos A; Alonso E; Palma-Carlos ML; Palma-Carlos AG
Allerg Immunol (Paris); 2001 Jun; 33(6):225-8. PubMed ID: 11505805
[TBL] [Abstract][Full Text] [Related]
20. Effect of immunotherapy on sCD23 levels in patients allergic to Hymenoptera venom.
Forman SO; Reddy MM; Mazza DS; Meriney DK; Grieco MH
Ann Allergy Asthma Immunol; 1996 Oct; 77(4):282-4. PubMed ID: 8885804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
